APPENDIX D: ASCR REQUIRED DATA ELEMENTS (Version 13)

Size: px
Start display at page:

Download "APPENDIX D: ASCR REQUIRED DATA ELEMENTS (Version 13)"

Transcription

1 APPENDIX D: ASCR REQUIRED DATA ELEMENTS (Version 13) New Required Item by ASCR R - Required Fields, S - Supplemental Fields, * - When available CR Only - only need for Central Registry Data NPCR Collect Data Item Name Item Default Value Recommendation Code Number Record Type 10 R A CR Patient ID Number 20 R (Central Registry) Patient System ID-Hosp 21. Registry Type 30. FIN Coding System 35. Reserved Registry ID 40 R NPI--Registry ID 45. NAACCR Record Version 50 R Tumor Record Number 60. Addr at DX--City 70 R Addr at DX--State 80 R County at DX 90 R Addr at DX--Postal Code 100 R New Addr at DX--Country 102 R USA Census Tract 1970/80/ RH* Census Cod Sys 1970/80/ RH* Census Tract R CR Census Tract R Census Tract Cod Sys--Alt 140 CR (new) Census Tr Poverty Indictr 145 Marital Status at DX 150. Race R Race R Race R Race R Race R Race Coding Sys--Current 170. Race Coding Sys--Original 180. Spanish/Hispanic Origin 190 R NHIA Derived Hisp Origin 191 D CR IHS Link 192 R* Page 32

2 Race--NAPIIA(derived API) 193 R Computed Ethnicity 200 R Computed Ethnicity Source 210 R Sex 220 R Age at Diagnosis 230 R Date of Birth 240 R Date of Birth Flag 241 R Birthplace 250 RH New Birthplace--State 252 R* New Birthplace--Country 254 R* USA Religion 260 Census Occ Code R* CR (New) Census Ind Code Census Ind Code R* CR (New) Census Occ Code Occupation Source 290 R* Industry Source 300 R* Text--Usual Occupation 310 R* Text--Usual Industry 320 R* Census Occ/Ind Sys R* Tobacco History 340 Alcohol History 350 Family History of Cancer 360 CR Census Block Group CR Census Block Group Census Tr Cert 1970/80/ RH* CR Census Tr Certainty R CR GIS Coordinate Quality 366 R* CR Census Tr Certainty R CR Census Block Grp Reserved Sequence Number--Central 380 R Date of Diagnosis 390 R Date of Diagnosis Flag 391 R Primary Site 400 R Laterality 410 R Morph Type &Behav ICD-O Histology (92-00) ICD-O RH Behavior (92-00) ICD-O RH Page 33

3 Date of Mult Tumors Flag 439. Grade 440 R Grade Path Value 441 R* Ambiguous Terminology DX 442. Date Conclusive DX 443 R* Mult Tum Rpt as One Prim 444. Date of Mult Tumors 445 R* Multiplicity Counter 446. Number of Tumors/Hist 447 Date Conclusive DX Flag 448. Grade Path System 449 R* Site Coding Sys--Current 450 R 5 Site Coding Sys--Original 460. Morph Coding Sys--Current 470 R 8 Morph Coding Sys--Originl 480. Diagnostic Confirmation 490 R Type of Reporting Source 500 R Casefinding Source 501 R Screening Date 510 Screening Result 520 Morph--Type&Behav ICD-O Histologic Type ICD-O R Behavior Code ICD-O R Reserved Reporting Hospital FAN 538 Reporting Facility 540 R NPI--Reporting Facility 545 R* Accession Number--Hosp 550. Sequence Number--Hospital 560. Abstracted By 570. Date of 1st Contact 580 R Date of 1st Contact Flag 581 R Date of Inpt Adm 590. Date of Inpt Adm Flag 591. Date of Inpt Disch 600. Date of Inpt Disch Flag 601. Inpatient Status 605. Class of Case 610 R Year First Seen This CA 620 Page 34

4 Primary Payer at DX 630 R* Inpatient/Outpt Status 640 Presentation at CA Conf 650 Date of CA Conference 660 RX Hosp--ASA Class 665. RX Hosp--Surg App RX Hosp--Surg Prim Site 670. RX Hosp--Scope Reg LN Sur 672. RX Hosp--Surg Oth Reg/Dis 674. RX Hosp--Reg LN Removed 676. RX Hosp--Surg Timing 678. Reserved RX Hosp--Radiation 690. RX Hosp--Chemo 700. RX Hosp--Hormone 710. RX Hosp--BRM 720. RX Hosp--Other 730. RX Hosp--DX/Stg Proc 740. RX Hosp--Screen/BX Proc1 742 RX Hosp--Screen/BX Proc2 743 RX Hosp--Screen/BX Proc3 744 RX Hosp--Screen/BX Proc4 745 RX Hosp--Surg Site RX Hosp--Scope Reg RX Hosp--Surg Oth Reserved SEER Summary Stage R+ SEER Summary Stage RH Loc/Reg/Distant Stage 770 Extent of Disease 10-Dig 779. EOD--Tumor Size 780. EOD--Extension 790. EOD--Extension Prost Path 800. EOD--Lymph Node Involv 810. Regional Nodes Positive 820 R Regional Nodes Examined 830 R EOD--Old 13 Digit 840. EOD--Old 2 Digit 850. EOD--Old 4 Digit 860. Page 35

5 Coding System for EOD TNM Path T 880. TNM Path N 890. TNM Path M 900. TNM Path Stage Group 910. TNM Path Descriptor 920. TNM Path Staged By 930. TNM Clin T 940. TNM Clin N 950. TNM Clin M 960. TNM Clin Stage Group 970. TNM Clin Descriptor 980. TNM Clin Staged By 990. TNM Other T 1000 TNM Other N 1010 TNM Other M 1020 TNM Other Stage Group 1030 TNM Other Staged By 1040 TNM Other Descriptor 1050 TNM Edition Number Other Staging System 1070 Date of 1st Positive BX 1080 Site of Distant Met Site of Distant Met Site of Distant Met Pediatric Stage Pediatric Staging System Pediatric Staged By Tumor Marker Tumor Marker Tumor Marker Reserved Lymph-vascular Invasion 1182 RS Reserved RX Date Surgery 1200 R RX Date Surgery Flag 1201 R RX Date Radiation 1210 RS RX Date Radiation Flag 1211 RS RX Date Chemo 1220 RS Page 36

6 RX Date Chemo Flag 1221 RS RX Date Hormone 1230 RS RX Date Hormone Flag 1231 RS RX Date BRM 1240 RS RX Date BRM Flag 1241 RS RX Date Other 1250 RS RX Date Other Flag 1251 RS Date of Initial RX SEER 1260 R# Date of Initial RX SEER Flag 1261 R# Date of 1st Crs RX CoC 1270 R# Date of 1st Crs Rx CoC Flag 1271 R# RX Date DX/Stg Proc RX Date Dx/Stg Proc Flag RX Summ--Treatment Status 1285 RS# RX Summ--Surg Prim Site 1290 R RX Summ--Scope Reg LN Sur 1292 R RX Summ--Surg Oth Reg/Dis 1294 R RX Summ--Reg LN Examined Reserved RX Summ--Surgical Approch RX Summ--Surgical Margins RX Summ--Reconstruct 1st Reason for No Surgery 1340 R RX Summ--DX/Stg Proc 1350 RX Summ--Radiation 1360 RS RX Summ--Rad to CNS 1370 RX Summ--Surg/Rad Seq 1380 RS RX Summ--Chemo 1390 RS RX Summ--Hormone 1400 RS RX Summ--BRM 1410 RS RX Summ--Other 1420 RS Reason for No Radiation 1430 RS Reason for No Chemo 1440 Reason for No Hormone 1450 RX Coding System--Current 1460 R 06 (FORDS) Protocol Eligibility Stat 1470 Protocol Participation 1480 Referral to Support Serv 1490 Retired First Course Calc Method 1500 Page 37

7 Rad--Regional Dose: CGY Rad--No of Treatment Vol Rad--Elapsed RX Days 1530 Rad--Treatment Volume Rad--Location of RX Rad--Intent of Treatment 1560 Rad--Regional RX Modality 1570 RS Rad--RX Completion Status 1580 Rad--Local Control Status 1590 Chemotherapy Field Chemotherapy Field Chemotherapy Field Chemotherapy Field RX Summ--Systemic/Sur Seq 1639 RS RX Summ--Surgery Type RX Summ--Screen/BX Proc RX Summ--Screen/BX Proc RX Summ--Screen/BX Proc RX Summ--Screen/BX Proc RX Summ--Surg Site RX Summ--Scope Reg RX Summ--Surg Oth Reserved Subsq RX 2nd Course Date Subsq RX 2ndCrs Date Flag Subsq RX 2nd Course Codes Subsq RX 2nd Course Surg Subsq RX 2nd Course Rad Subsq RX 2nd Course Chemo Subsq RX 2nd Course Horm Subsq RX 2nd Course BRM Subsq RX 2nd Course Oth Subsq RX 2nd--Scope LN SU Subsq RX 2nd--Surg Oth Subsq RX 2nd--Reg LN Rem Subsq RX 3rd Course Date Subsq RX 3rdCrs Date Flag Subsq RX 3rd Course Codes Subsq RX 3rd Course Surg Page 38

8 Subsq RX 3rd Course Rad Subsq RX 3rd Course Chemo Subsq RX 3rd Course Horm Subsq RX 3rd Course BRM Subsq RX 3rd Course Oth Subsq RX 3rd--Scope LN Su Subsq RX 3rd--Surg Oth Subsq RX 3rd--Reg LN Rem Subsq RX 4th Course Date Subsq RX 4thCrs Date Flag Subsq RX 4th Course Codes Subsq RX 4th Course Surg Subsq RX 4th Course Rad Subsq RX 4th Course Chemo Subsq RX 4th Course Horm Subsq RX 4th Course BRM Subsq RX 4th Course Oth Subsq RX 4th--Scope LN Su Subsq RX 4th--Surg Oth Subsq RX 4th--Reg LN Rem Subsq RX 5th Course Date 1720 Subsq RX 5th Course Codes 1730 Subsq RX 5th Course Surg 1731 Subsq RX 5th Course Rad 1732 Subsq RX 5th Course Chemo 1733 Subsq RX 5th Course Horm 1734 Subsq RX 5th Course BRM 1735 Subsq RX 5th Course Oth 1736 Subsq RX 5th--Scope LN Su 1737 Subsq RX 5th--Surg Oth 1738 Subsq RX 5th--Reg LN Rem 1739 Reserved Subsq RX--Reconstruct Del Date of Last Contact 1750 R Date of Last Contact Flag 1751 R Date of Death--Canada Date of Death--CanadaFlag Vital Status 1760 R Cancer Status Page 39

9 Quality of Survival Follow-Up Source 1790 R* CR Follow-up Source Central 1791 R Next Follow-Up Source Addr Current--City Addr Current--State Addr Current--Postal Code New Addr Current--Country 1832 USA Reserved County--Current Follow-Up Contact--City Follow-Up Contact--State Follow-Up Contact--Postal New Follow-Up Contact--Country 1847 Changed to 2 digital Unusual Follow-Up Method characters ( ) Recurrence Date--1st Recurrence Date--1st Flag Recurrence Distant Sites 1870 Recurrence Distant Site Recurrence Distant Site Recurrence Distant Site Recurrence Type--1st Recurrence Type--1st--Oth 1890 Reserved Cause of Death 1910 R 0000 (live) ICD Revision Number 1920 R 0 (live) Autopsy 1930 R 0 (live) Place of Death 1940 RH New Place of Death--State 1942 R Column New Place of Death--Country 1944 R* Column Site (73-91) ICD-O Morph (73-91) ICD-O Histology (73-91) ICD-O Behavior (73-91) ICD-O Grade (73-91) ICD-O ICD-O-2 Conversion Flag Over-ride SS/NodesPos Over-ride SS/TNM-N Page 40

10 Over-ride SS/TNM-M Over-ride SS/DisMet Over-ride Acsn/Class/Seq Over-ride HospSeq/DxConf Over-ride CoC-Site/Type Over-ride HospSeq/Site Over-ride Site/TNM-StgGrp Over-ride Age/Site/Morph 1990 R Over-ride SeqNo/DxConf 2000 R Over-ride Site/Lat/SeqNo 2010 R Over-ride Surg/DxConf 2020 R Over-ride Site/Type 2030 R Over-ride Histology 2040 R Over-ride Report Source 2050 R Over-ride Ill-define Site 2060 R Over-ride Leuk, Lymphoma 2070 R Over-ride Site/Behavior 2071 R Over-ride Site/EOD/DX Dt Over-ride Site/Lat/EOD Over-ride Site/Lat/Morph 2074 R Reserved CRC CHECKSUM Date Case Initiated Date Case Completed Date Case Completed--CoC Date Case Last Changed Date Case Report Exported 2110 R CR Date Case Report Received 2111 R CR Date Case Report Loaded 2112 R Date Tumor Record Availbl 2113 R Future Use Timeliness Future Use Timeliness ICD-O-3 Conversion Flag 2116 R SEER Coding Sys--Current D Coding Manual SEER Coding Sys--Original CoC Coding Sys--Current CoC Coding Sys--Original Subsq Report for Primary 2160 Page 41

11 Vendor Name SEER Type of Follow-Up SEER Record Number Diagnostic Proc Reserved State/Requestor Items Name--Last 2230 R Name--First 2240 R Name--Middle 2250 R Name--Prefix Name--Suffix Name--Alias 2280 R Name--Spouse/Parent Medical Record Number 2300 R Military Record No Suffix Social Security Number 2320 R Addr at DX--No & Street 2330 R Addr at DX--Supplementl 2335 R Addr Current--No & Street CR Latitude 2352 R* CR Longitude 2354 R* Addr Current--Supplementl Telephone DC State 2370 DC State File Number 2380 R Name--Maiden 2390 R Follow-Up Contact--No&St Follow-Up Contact--Suppl Follow-Up Contact--Name Reserved Institution Referred From NPI--Inst Referred From Institution Referred To NPI--Inst Referred To Last Follow-Up Hospital 2430 Following Registry NPI--Following Registry Reserved Physician--Managing Page 42

12 NPI--Physician--Managing Physician--Follow-Up NPI--Physician--Follow-Up Physician--Primary Surg NPI--Physician--Primary Surg Physician NPI--Physician Physician NPI--Physician Reserved Text--DX Proc--PE 2520 R^ Text--DX Proc--X-ray/Scan 2530 R^ Text--DX Proc--Scopes 2540 R^ Text--DX Proc--Lab Tests 2550 R^ Text--DX Proc--Op 2560 R^ Text--DX Proc--Path 2570 R^ Text--Primary Site Title 2580 R^ Text--Histology Title 2590 R^ Text--Staging 2600 R^ RX Text--Surgery 2610 R^ RX Text--Radiation (Beam) 2620 R^ RX Text--Radiation Other 2630 R^ RX Text--Chemo 2640 R^ RX Text--Hormone 2650 R^ RX Text--BRM 2660 R^ RX Text--Other 2670 R^ Text--Remarks Text--Place of Diagnosis CS PreRx Tumor Size CS PreRx Extension CS PreRx Tum Sz/Ext Eval CS PreRx Lymph Nodes CS PreRx Reg Nodes Eval CS PreRx Mets at DX CS PreRx Mets Eval CS PostRx Tumor Size CS PostRx Extension CS PostRx Lymph Nodes CS PostRx Mets at DX Page 43

13 CS Tumor Size 2800 R CS Extension 2810 R+ CS Tumor Size/Ext Eval 2820 R+ CS Lymph Nodes 2830 R+ CS Lymph Nodes Eval 2840 R* CS Mets at DX 2850 R+ CS Mets at Dx-Bone CS Mets at Dx-Brain CS Mets at Dx-Liver CS Mets at Dx-Lung CS Mets Eval 2860 R* CS Site-Specific Factor RS* CS Site-Specific Factor RS CS Site-Specific Factor RS CS Site-Specific Factor RS CS Site-Specific Factor RS CS Site-Specific Factor RS CS Site-Specific Factor RS CS Site-Specific Factor RS CS Site-Specific Factor RS CS Site-Specific Factor RS CS Site-Specific Factor RS* CS Site-Specific Factor RS* CS Site-Specific Factor RS* CS Site-Specific Factor RS* CS Site-Specific Factor RS* CS Site-Specific Factor RS* CS Site-Specific Factor RS* CS Site-Specific Factor RS* CS Site-Specific Factor RS CS Site-Specific Factor RS CS Site-Specific Factor RS CS Site-Specific Factor RS CS Site-Specific Factor RS* CS Site-Specific Factor RS* CS Site-Specific Factor RS* CS Version Input Original 2935 R CS Version Derived 2936 R+ CS Version Input Current 2937 R Page 44

14 Derived AJCC-6 T Derived AJCC-6 T Descript Derived AJCC-6 N Derived AJCC-6 N Descript Derived AJCC-6 M Derived AJCC-6 M Descript Derived AJCC-6 Stage Grp Derived SS Derived SS D+ Derived AJCC--Flag Derived SS1977--Flag Derived SS2000--Flag 3050 D+ Archive FIN NPI--Archive FIN Comorbid/Complication Comorbid/Complication Comorbid/Complication Comorbid/Complication Comorbid/Complication Comorbid/Complication Comorbid/Complication Comorbid/Complication Comorbid/Complication Comorbid/Complication ICD Revision Comorbid RX Date Most Defin Surg RX Date Mst Defn Srg Flag RX Date Surgical Disch RX Date Surg Disch Flag Readm Same Hosp 30 Days Rad--Boost RX Modality Rad--Boost Dose cgy RX Date Radiation Ended RX Date Rad Ended Flag RX Date Systemic RX Date Systemic Flag RX Summ--Transplnt/Endocr 3250 RS Pain Assessment 3260 RX Summ--Palliative Proc Page 45

15 RX Hosp--Palliative Proc RuralUrban Continuum D RuralUrban Continuum D Derived AJCC-7 T 3400 D* Derived AJCC-7 T Descript 3402 D* Derived AJCC-7 N 3410 D* Derived AJCC-7 N Descript 3412 D* Derived AJCC-7 M 3420 D* Derived AJCC-7 M Descript 3422 D* Derived AJCC-7 Stage Grp 3430 D* Derived PreRx-7 T Derived PreRx-7 T Descrip Derived PreRx-7 N Derived PreRx-7 N Descrip Derived PreRx-7 M Derived PreRx-7 M Descrip Derived PreRx-7 Stage Grp Derived PostRx-7 T Derived PostRx-7 N Derived PostRx-7 M Derived PostRx-7 Stge Grp Derived Neoadjuv Rx Flag SEER Site-Specific Fact SEER Site-Specific Fact SEER Site-Specific Fact SEER Site-Specific Fact SEER Site-Specific Fact SEER Site-Specific Fact Over-ride CS R Over-ride CS R Over-ride CS R Over-ride CS R Over-ride CS R Over-ride CS R Over-ride CS R Over-ride CS R Over-ride CS R Over-ride CS R Over-ride CS R Page 46

16 Over-ride CS R Over-ride CS R Over-ride CS R Over-ride CS R Over-ride CS R Over-ride CS R Over-ride CS R Over-ride CS R Over-ride CS R Secondary Daignosis Secondary Daignosis Secondary Daignosis Secondary Daignosis Secondary Daignosis Secondary Daignosis Secondary Daignosis Secondary Daignosis Secondary Daignosis Secondary Daignosis Path Reporting Fac ID Path Reporting Fac ID Path Reporting Fac ID Path Reporting Fac ID Path Reporting Fac ID Path Report Number Path Report Number Path Report Number Path Report Number Path Report Number Path Order Phys Lic No Path Order Phys Lic No Path Order Phys Lic No Path Order Phys Lic No Path Order Phys Lic No Column Column Column Column Column Column Column Column Column Column Page 47

17 Path Ordering Fac No Path Ordering Fac No Path Ordering Fac No Path Ordering Fac No Path Ordering Fac No Path Date Spec Collect Path Date Spec Collect Path Date Spec Collect Path Date Spec Collect Path Date Spec Collect Path Report Type Path Report Type Path Report Type Path Report Type Path Report Type FupUnusual - Unusual F-up Methods - use to indicate whether patients want the medical record to be released for other purpose 00 - OK to release 01 Not release Out of State 02 - Do not release (HIPPA) (Example: For use when a patient request that their medical record information not be released.) 03 Do not release (Interstate Data Exchange Cases + HIPAA) 04 - Do not release (VA) 05 - Do not release (Interstate Data Exchange Cases + VA) 06 - Do not release (VA + HIPAA) 07 - Do not release (Interstate Data Exchange Cases + HIPAA+VA) Page 48

18 ASCR continue collecting these retired data items or AL specific items Name Position Item Number Length Follow-up Contact--Phone Column Tobacco History Column Alcohol History Column Family History of Cancer Column Religion Column Site of Distant Site 1 Column Site of Distant Site 2 Column Site of Distant Site 3 Column Recurrence Distant Site 1 Column Recurrence Distant Site 2 Column Recurrence Distant Site 3 Column Over-ride SS/DisMel1 Column Date of 1st Positive BX Column Date of 1st Positive BX Flag Column Code Fam Hist of CA Tobacco History Alcohol History 0 No Never Used No history of alcohol use 1 Yes Cigarette smoker, current Current use of alcohol 2 Cigar/pipe smoker, current Past history of alcohol use, does not currently use 3 Snuff /Chew/smokeless, current 4 Combination use, current 5 Previous Use 9 Unknown Unknown Unknown Page 49

ASCR Data Items for V14 ASCR Requirement: R - Required Fields, S - Supplemental Fields, * - When available CR Only - only need for Central Registry

ASCR Data Items for V14 ASCR Requirement: R - Required Fields, S - Supplemental Fields, * - When available CR Only - only need for Central Registry ASCR Data Items for V14 ASCR Requirement: R - Required Fields, S - Supplemental Fields, * - When available CR Only - only need for Central Registry Data Item Name Data Item Number NPCR Collect Recommendation

More information

Standards for Cancer Registries, Volume II: Data Standards and Data Dictionary, Eighth Edition. COC Collect. COC Transmit

Standards for Cancer Registries, Volume II: Data Standards and Data Dictionary, Eighth Edition. COC Collect. COC Transmit 10 Record Type R R NAACCR 20 Patient ID Number R R R Reporting Registry 30 Registry Type NAACCR 35 FIN Coding System S NAACCR 37 Reserved 00 40 Registry ID S R R NAACCR 50 NAACCR Record Version R R NAACCR

More information

2010 Cancer Data Collection Updates: Standards Volume II, Introduction. What s New for 2010

2010 Cancer Data Collection Updates: Standards Volume II, Introduction. What s New for 2010 2010 Cancer Data Collection Updates: Standards Volume II, Version 12 NAACCR 2009 2010 Webinar Series Introduction What s New for 2010 Record length and record layout New/changed data items Multiple Primary

More information

Pathology: Grade 1 infiltrating ductal carcinoma with associated DCIS, Lymphvascular invasion present. ER+, PR+. Her 2/ IHC 1+, negative

Pathology: Grade 1 infiltrating ductal carcinoma with associated DCIS, Lymphvascular invasion present. ER+, PR+. Her 2/ IHC 1+, negative GATRA 2016 Breast Case Demographics Name: Autumn Leaf Sex: F Date of Birth: 3/26/75 SSN: 098765432 Race: African American Marital Status: Single Address: 3615 Burnt Hickory Trail, Helen, GA 37285, White

More information

1. Laterality, Primary Site E:Lateral & Site conflict Laterality (295) = 0 _ 2 Primary Site (291) = C711 Date of Diagnosis (283) =

1. Laterality, Primary Site E:Lateral & Site conflict Laterality (295) = 0 _ 2 Primary Site (291) = C711 Date of Diagnosis (283) = Follow-up, Data Quality and Utilization Lesson 8 Page 5: Correcting the Edits Report Instructions: Use the spaces provided to fix the edit by providing the valid value for the incorrect data item. This

More information

1. Laterality, Primary Site E:Lateral & Site conflict Laterality (295) = 0 _ Primary Site (291) = C711 Date of Diagnosis (283) =

1. Laterality, Primary Site E:Lateral & Site conflict Laterality (295) = 0 _ Primary Site (291) = C711 Date of Diagnosis (283) = Follow-up, Data Quality and Utilization Lesson 8 Page 5: Correcting the Edits Report Instructions: Use the spaces provided to fix the edit by providing the valid value for the incorrect data item. This

More information

The Components of an Abstract. Alfreda Woods, BS, CHES, CTR Program Manager, DCCR DelMarVa-DC Educational Conference October 12, 2018

The Components of an Abstract. Alfreda Woods, BS, CHES, CTR Program Manager, DCCR DelMarVa-DC Educational Conference October 12, 2018 The Components of an Abstract Alfreda Woods, BS, CHES, CTR Program Manager, DCCR DelMarVa-DC Educational Conference October 12, 2018 1 Abstracts Should Tell A Story 2 The Components of an Abstract Who

More information

I.2 CNExT This section was software specific and deleted in 2008.

I.2 CNExT This section was software specific and deleted in 2008. CANCER REPORTING IN CALIFORNIA: ABSTRACTING AND CODING PROCEDURES FOR HOSPITALS California Cancer Reporting System Standards, Volume I Changes and Clarifications 8th th Edition Revised May 2008 SECTION

More information

Requirements for Abstracted Text

Requirements for Abstracted Text Slide 1 Requirements for Abstracted Text Principles of Abstracting Lesson 3: Purpose of Text Slide 2 Available Text Fields Place of Diagnosis Immunotherapy Chemotherapy Hormone Therapy Other Therapy Radiation

More information

CANCER REPORTING IN CALIFORNIA: ABSTRACTING AND CODING PROCEDURES California Cancer Reporting System Standards, Volume I

CANCER REPORTING IN CALIFORNIA: ABSTRACTING AND CODING PROCEDURES California Cancer Reporting System Standards, Volume I CANCER REPORTING IN CALIFORNIA: ABSTRACTING AND CODING PROCEDURES California Cancer Reporting System Standards, Volume I Changes and Clarifications 16 th Edition April 15, 2016 Quick Look- Updates to Volume

More information

NCDB Vendor Webinar: NCDB Call for Data January 2018 and Upcoming RQRS Revisions

NCDB Vendor Webinar: NCDB Call for Data January 2018 and Upcoming RQRS Revisions NCDB Vendor Webinar: NCDB Call for Data January 2018 and Upcoming RQRS Revisions American American College College of of Surgeons 2013 Content 2014 Content cannot be be reproduced or or repurposed without

More information

FORDS. Facility Oncology Registry Data Standards Revised for 2010 (Incorporates all updates since originally published in July 2002)

FORDS. Facility Oncology Registry Data Standards Revised for 2010 (Incorporates all updates since originally published in July 2002) FORDS Facility Oncology Registry Data Standards Revised for 2010 (Incorporates all updates since originally published in July 2002) Includes updates to May 1, 2010 See Appendix C for a summary of changes.

More information

Alternate Name Item # Length Source of Standard Column # Alternate Name Item # Length Source of Standard Column #

Alternate Name Item # Length Source of Standard Column # Alternate Name Item # Length Source of Standard Column # RESERVED 04 750 46 482-527 RESERVED 05 1180 50 705-754 RESERVED 06 1190 45 943-987 RESERVED 07 1300 50 1065-1114 RESERVED 08 1650 50 1244-1293 RESERVED 09 1740 50 1397-1446 RESERVED 10 1835 50 2415-2464

More information

QUICK-START GUIDE NCDB Participant Use File (NCDB PUF)

QUICK-START GUIDE NCDB Participant Use File (NCDB PUF) QUICK-START GUIDE 2015 NCDB Participant Use File (NCDB PUF) The data included in this zipped file are provided in a flat text file format, and should be read with software such as SAS, SPSS (PASW), STATA,

More information

Abstract Code Manual

Abstract Code Manual 16th Edition Abstract Code Manual MISSOURI CANCER REGISTRY AND RESEARCH CENTER University of Missouri Columbia 2016 Revised Missouri Cancer Registry and Research Center Abstract Code Manual 16th Edition

More information

CCARM. Cancer Collection and Reporting Manual Revised for 2016

CCARM. Cancer Collection and Reporting Manual Revised for 2016 This publication was supported by cooperative agreement N.C. U55CCU421885 awarded to the from the Centers for Disease Control and Prevention. Its contents are solely the responsibility of the authors and

More information

Abstracting and Coding Boot Camp: Cancer Case Scenarios

Abstracting and Coding Boot Camp: Cancer Case Scenarios NAACC R 2015-2016 Webinar Series Abstracting and Coding Boot Camp: Cancer Case Scenarios NAACCR 2015 2016 Webinar Series Presented by: Angela Martin amartin@naaccr.org Jim Hofferkamp jhofferkamp@naaccr.org

More information

ON-LINE REGISTRATION FCDS MONOGRAPH: 2004 ADMISSIONS (TOTAL), ANALYTIC CASES ONLY FLORIDA ANNUAL CANCER REPORT: 2001 INCIDENCE

ON-LINE REGISTRATION FCDS MONOGRAPH: 2004 ADMISSIONS (TOTAL), ANALYTIC CASES ONLY FLORIDA ANNUAL CANCER REPORT: 2001 INCIDENCE ON-LINE REGISTRATION FOR THE FCDS ANNUAL CONFERENCE, JULY 27-28, 2006, AND BROCHURE FCDS 2006 IMPLEMENTATION GUIDE FOR NAACCR VERSION 11 (REVISED 5/22/2006; ADDS NEW AND UPDATED EDITS FOR CASES RECEIVED

More information

2018 IMPLEMENTATION UPDATE: WHAT S NEW IN STAGING FOR 2018?

2018 IMPLEMENTATION UPDATE: WHAT S NEW IN STAGING FOR 2018? 2018 IMPLEMENTATION UPDATE: WHAT S NEW IN STAGING FOR 2018? SESSION 2 10/20/17 Q&A Please submit all questions concerning webinar content through the Q&A panel. A recording of today s session, the Q&A,

More information

North American Association of Central Cancer Registries, Inc. (NAACCR)

North American Association of Central Cancer Registries, Inc. (NAACCR) North American Association of Central Cancer Registries, Inc. (NAACCR) 2018 Implementation Guidelines and Recommendations (For NAACCR Standards Volume II, Data Standards and Data Dictionary, Version 18,

More information

North American Association of Central Cancer Registries, Inc. (NAACCR)

North American Association of Central Cancer Registries, Inc. (NAACCR) North American Association of Central Cancer Registries, Inc. (NAACCR) 2016 Implementation Guidelines and Recommendations (For NAACCR Standards Volume II, Data Standards and Data Dictionary, Version 16,

More information

CERVIX MEASURE SPECIFICATIONS

CERVIX MEASURE SPECIFICATIONS Cancer Programs Practice Profile Reports (CP 3 R) CERVIX MEASURE SPECIFICATIONS Introduction The Commission on Cancer s (CoC) National Cancer Data Base (NCDB) staff has undertaken an effort to improve

More information

Q: How do you clinically code the N if the nodes are stated to be positive on mammogram/us or other imaging? No biopsy of nodes was done.

Q: How do you clinically code the N if the nodes are stated to be positive on mammogram/us or other imaging? No biopsy of nodes was done. Q&A Breast Webinar Q: One of my investigators is interested in knowing when Oncotype DX data collection was implemented. That data is collected in SSFs 22 and 23. I remember that the SSFs for breast were

More information

North American Association of Central Cancer Registries, Inc. (NAACCR)

North American Association of Central Cancer Registries, Inc. (NAACCR) North American Association of Central Cancer Registries, Inc. (NAACCR) 2015 Implementation Guidelines and Recommendations (For NAACCR Standards Volume II, Data Standards and Data Dictionary, Version 15,

More information

Q&A. Overview. Collecting Cancer Data: Prostate. Collecting Cancer Data: Prostate 5/5/2011. NAACCR Webinar Series 1

Q&A. Overview. Collecting Cancer Data: Prostate. Collecting Cancer Data: Prostate 5/5/2011. NAACCR Webinar Series 1 Collecting Cancer Data: Prostate NAACCR 2010-2011 Webinar Series May 5, 2011 Q&A Please submit all questions concerning webinar content through the Q&A panel Overview NAACCR 2010-2011 Webinar Series 1

More information

Setting the stage for change: upgrading the physician cancer case reporting application in New York

Setting the stage for change: upgrading the physician cancer case reporting application in New York Setting the stage for change: upgrading the physician cancer case reporting application in New York April Austin New York State Cancer Registry (NYSCR) July 12, 2018 June 13, 2018 Aerial view of Thousand

More information

FCDS Text and Documentation Requirements: A Key Component to Providing High Quality Data

FCDS Text and Documentation Requirements: A Key Component to Providing High Quality Data FCDS Text and Documentation Requirements: A Key Component to Providing High Quality Data 2011 FCDS Educational Webcast Series Mayra Espino, BA, RHIT, CTR Steven Peace, BS, CTR August 18, 2011 CDC-NPCR

More information

Donna M. Hansen, CTR Auditor & Training Coordinator California Cancer Registry

Donna M. Hansen, CTR Auditor & Training Coordinator California Cancer Registry Donna M. Hansen, CTR Auditor & Training Coordinator California Cancer Registry April 2015 2015 Data Changes New Data Items Revised Data Items ICD-0-3 Reportability Change New ICDO Terms and Codes SEER

More information

Commission on Cancer Updates

Commission on Cancer Updates Commission on Cancer Updates OBJECTIVES PROVIDE CANCER REGISTRARS WITH INFORMATION ABOUT CURRENT COC 2018 CHANGES DISCUSS CHANGES RELATED TO CANCER REGISTRY DATA COLLECTION DISCUSS CHANGES RELATED TO CANCER

More information

Standards for Cancer Registries, Volume I. Data Exchange Standards and Record Descriptions

Standards for Cancer Registries, Volume I. Data Exchange Standards and Record Descriptions Standards for Cancer Registries, Volume I Data Exchange Standards and Record Descriptions Version 18 March 2018 Edited by Lori A. Havener, CTR Program Manager of Standards North American Association of

More information

CANCER REPORTING IN CALIFORNIA: ABSTRACTING AND CODING PROCEDURES FOR HOSPITALS California Cancer Reporting System Standards, Volume I

CANCER REPORTING IN CALIFORNIA: ABSTRACTING AND CODING PROCEDURES FOR HOSPITALS California Cancer Reporting System Standards, Volume I CANCER REPORTING IN CALIFORNIA: ABSTRACTING AND CODING PROCEDURES FOR HOSPITALS California Cancer Reporting System Standards, Volume I SUMMARY OF YEAR 2004 DATA CHANGES This document will provide a summary

More information

American College of Surgeons 2014 Content cannot be reproduced or repurposed without written permission of the American College of Surgeons.

American College of Surgeons 2014 Content cannot be reproduced or repurposed without written permission of the American College of Surgeons. Revision of the FORDS Manual: A Process Dependent on Registrar and Clinician Input Frederick L. Greene, MD FACS Medical Director, Cancer Data Services, Levine Cancer Institute, Charlotte, NC 1 2 Disease

More information

Part VIII Entering Information Into the Urology Report Form

Part VIII Entering Information Into the Urology Report Form North Carolina Central Cancer Registry Instructions and Reporting Requirements Module 8 Electronic Reporting For Urology Physician Practices May 2013 North Carolina Central Cancer Registry State Center

More information

NAACR Treatment Webinar Quiz 1

NAACR Treatment Webinar Quiz 1 NAACR Treatment Webinar Quiz 1 1. Which of the following would NOT be considered cancer-directed treatment? a. Hemicolectomy b. Incisional biopsy c. Whole breast radiation d. MRI e. All of the above f.

More information

Michigan Cancer Surveillance Program

Michigan Cancer Surveillance Program Michigan Cancer Surveillance Program Supplemental Guidance for the Implementation Guide for Ambulatory Healthcare Provider Reporting to Central Cancer Registries, HL7 Clinical Document Architecture (CDA)

More information

Cancer Registry Abstracting FLORIDA CANCER DATA SYSTEM

Cancer Registry Abstracting FLORIDA CANCER DATA SYSTEM Cancer Registry 1 Learning Objectives 2 Integrate previously learned principles of cancer identification (anatomy, casefinding, site and histology identification principles, staging principles, and treatment

More information

AJCC TNM STAGING UPDATES ARE YOU READY FOR TNM?

AJCC TNM STAGING UPDATES ARE YOU READY FOR TNM? AJCC TNM STAGING UPDATES ARE YOU READY FOR TNM? FCRA Annual Conference Boca Raton, Florida 7/26/2016 Steven Peace, CTR 1 Introduction Order AJCC Cancer Staging Manual, 7 th ed. How To Use - AJCC Cancer

More information

Who What When Where Why. Case Finding 5 W s. NAACCR Webinar Series. Presented by: Joyce L. Jones, CTR Professional Registry Services, LLC

Who What When Where Why. Case Finding 5 W s. NAACCR Webinar Series. Presented by: Joyce L. Jones, CTR Professional Registry Services, LLC Who What When Where Why Case Finding 5 W s NAACCR 2010-2011 Webinar Series Presented by: Joyce L. Jones, CTR Professional Registry Services, LLC Agenda Case Finding Purpose Reportable lists Benign intracranial

More information

MCR: MANAGEMENT OF 2018 CHANGES. By: Maricarmen Traverso-Ortiz MPH, CGG, CTR

MCR: MANAGEMENT OF 2018 CHANGES. By: Maricarmen Traverso-Ortiz MPH, CGG, CTR MCR: MANAGEMENT OF 2018 CHANGES By: Maricarmen Traverso-Ortiz MPH, CGG, CTR LEARNING OBJECTIVES Discuss a summary of the new changes for 2018 Overview of how the Maryland Cancer Registry is managing and

More information

VISUAL EDITING GUIDELINES March 2015 (revised June 2015)

VISUAL EDITING GUIDELINES March 2015 (revised June 2015) March 2015 (revised June 2015) Developed for The Cancer Registry of Greater California under the direction of Winny Roshala, BA, CTR, Data Quality Control Director By the following contributing Authors:

More information

4/10/2018. SEER EOD and Summary Stage. Overview KCR 2018 SPRING TRAINING. What is SEER EOD? Ambiguous Terminology General Guidelines

4/10/2018. SEER EOD and Summary Stage. Overview KCR 2018 SPRING TRAINING. What is SEER EOD? Ambiguous Terminology General Guidelines SEER EOD and Summary Stage KCR 2018 SPRING TRAINING Overview What is SEER EOD Ambiguous Terminology General Guidelines EOD Primary Tumor EOD Regional Nodes EOD Mets SEER Summary Stage 2018 Site Specific

More information

NAACCR Webinar Series 1

NAACCR Webinar Series 1 NAACCR 2009 2010 Webinar Series Collecting Cancer Data: Kidney 1 Questions Please use the Q&A panel to submit your questions Send questions to All Panelist 2 Fabulous Prizes 3 NAACCR 2009 2010 Webinar

More information

EVERYTHING YOU WANTED TO KNOW ABOUT. Robin Billet, MA, CTR, Head & Neck CTAP Member May 9, 2013

EVERYTHING YOU WANTED TO KNOW ABOUT. Robin Billet, MA, CTR, Head & Neck CTAP Member May 9, 2013 EVERYTHING YOU WANTED TO KNOW ABOUT. Robin Billet, MA, CTR, Head & Neck CTAP Member May 9, 2013 Head and Neck Coding and Staging Head and Neck Coding and Staging Anatomy & Primary Site Sequencing and MPH

More information

2018 New Required Data Items for Hospitals

2018 New Required Data Items for Hospitals 2018 New Required Data Items for Hospitals The NJSCR is a population-based registry, mandated by state law, that collects data on all cancer cases diagnosed and/or treated in New Jersey since October 1,

More information

FORDS to STORE: The Evolution of Cancer Registry Coding Frederick L. Greene, MD FACS Medical Director, Cancer Data Services Levine Cancer Institute

FORDS to STORE: The Evolution of Cancer Registry Coding Frederick L. Greene, MD FACS Medical Director, Cancer Data Services Levine Cancer Institute FORDS to STORE: The Evolution of Cancer Registry Coding Frederick L. Greene, MD FACS Medical Director, Cancer Data Services Levine Cancer Institute Charlotte, NC National Accreditation Program for Breast

More information

10/24/2013. Continuing Education Hours. Presentation Outline. Rule Makers for National Data Collection. NPCR Program Standards,

10/24/2013. Continuing Education Hours. Presentation Outline. Rule Makers for National Data Collection. NPCR Program Standards, 2 013-2014 QUALITY IMPROVEMENT EDUCATION AND TRAINING NCRA CEU # 2013-114 Continuing Education Hours Date Event Sponsor 7/25/2013-7/26/2013 CEU Hrs FCDS Annual Conference, Sunrise, FL FCDS 8.25 2013-115

More information

7/29/ Grade Coding Instructions ICD-O-3 Updates. Outline. Introduction to Coding Grade for 2014+

7/29/ Grade Coding Instructions ICD-O-3 Updates. Outline. Introduction to Coding Grade for 2014+ 2014 Grade Coding Instructions ICD-O-3 Updates 1 I M P L E M E N T A T I O N T I M E L I N E ( S ) 2 0 1 4 F C D S D A M A P P E N D I X H A N D O U T S F C D S A N N U A L C O N F E R E N C E O R L A

More information

Cancer as a Disease. Linda D. Rego, CTR March 2009

Cancer as a Disease. Linda D. Rego, CTR March 2009 Cancer as a Disease Linda D. Rego, CTR March 2009 Historic perspective First records date as early as 2500 B.C. In Egypt recorded on papyrus Outlines pharmacological, mechanical and magical treatments

More information

Stage Data Capture in Ontario

Stage Data Capture in Ontario Stage Data Capture in Ontario February 23, 2010 Agenda Refresher: Ontario s Stage Capture Project Collaborative Staging and Population Stage Reporting in Ontario Use of Stage Data in System Performance

More information

NAACCR Webinar 2018 SeriesImplementations and Timelines

NAACCR Webinar 2018 SeriesImplementations and Timelines NAACCR 2015-2016 Webinar 2018 SeriesImplementations and Timelines August 8, 2017 Session 1 Q&A Please submit all questions concerning webinar content through the Q&A panel. A recording of today s session,

More information

Canadian Cancer Registry Reference Guide For Years

Canadian Cancer Registry Reference Guide For Years Canadian Cancer Registry Reference Guide For Years 2000-2015 Compiled by: Edna Kalu, Zikuan Liu HOW TO OBTAIN MORE INFORMATION For more information about this guide or other services and data available

More information

Cancer Programs Practice Profile Reports (CP 3 R) Rapid Quality Reporting System (RQRS)

Cancer Programs Practice Profile Reports (CP 3 R) Rapid Quality Reporting System (RQRS) O COLON MEASURE SPECIFICATIONS Cancer Programs Practice Profile Reports (CP 3 R) Rapid Quality Reporting System (RQRS) Introduction The Commission on Cancer s (CoC) National Cancer Data Base (NCDB) staff

More information

The New CP 3 R Application And Revisions To Standard 4.6 Integration Of The NCDB With The Accreditation Process

The New CP 3 R Application And Revisions To Standard 4.6 Integration Of The NCDB With The Accreditation Process The New CP 3 R Application And Revisions To Standard 4.6 Integration Of The NCDB With The Accreditation Process Wednesday, April 29, 2009 at 11 AM Central M. Asa Carter, CTR Manager, Approvals and Standards

More information

AJCC TNM 6 th Edition Staging Input Data Dictionary

AJCC TNM 6 th Edition Staging Input Data Dictionary Catalogue no. 82-225-XIE No. 001 ISSN: 1715-2100 O ISBN: 0-662-41801-8 Manuals AJCC TNM 6 th Edition Staging Input Data Dictionary by Michel Cormier Health Statistics Division Client Custom Services Room

More information

2014 Reporting Requirements 2014 FCDS Annual Meeting Highlights

2014 Reporting Requirements 2014 FCDS Annual Meeting Highlights F l o r i d a S t a t e w i d e C a n c e r R e g i s t r y 2014 Reporting Requirements 2014 FCDS Annual Meeting Highlights 2014-2015 FCDS Webcast Series Steven Peace, CTR August 21, 2014 2014 FCDS Annual

More information

Cancer Data Uses and Dissemination. State of the State Florida Cancer Data System /21/2014. Certification. Presentation Outline

Cancer Data Uses and Dissemination. State of the State Florida Cancer Data System /21/2014. Certification. Presentation Outline F l o r i d a S t a t e w i d e C a n c e r R e g i s t r y 2014 Reporting Requirements 2014 FCDS Annual Meeting Highlights 2014 FCDS Annual Conference Recordings & Handouts http://fcds.med.miami.edu/inc/educationtraining.shtml

More information

AJCC 8 th Edition Staging. Introduction & Descriptors. Learning Objectives. This webinar is sponsored by

AJCC 8 th Edition Staging. Introduction & Descriptors. Learning Objectives. This webinar is sponsored by AJCC 8 th Edition Staging Introduction & Descriptors Donna M. Gress, RHIT, CTR Technical Editor, AJCC Cancer Staging Manual First Author, Chapter 1: Principles of Cancer Staging Validating science. Improving

More information

North American Association of Central Cancer Registries, Inc. (NAACCR)

North American Association of Central Cancer Registries, Inc. (NAACCR) North American Association of Central Cancer Registries, Inc. (NAACCR) Death Clearance Manual Minimum Requirements and Best Practices for Conducting Death Clearance Effective January 1, 2015 for Deaths

More information

Data Quality Analysis of Prostate Cancer Site Specific Factors in Metropolitan Detroit SEER Data,

Data Quality Analysis of Prostate Cancer Site Specific Factors in Metropolitan Detroit SEER Data, Data Quality Analysis of Prostate Cancer Site Specific Factors in Metropolitan Detroit SEER Data, 2004-2012 Jeanne Whitlock, MSLS, CTR Julie George, MS Ron Shore, MPH Fawn D. Vigneau, JD, MPH Metropolitan

More information

Newton Wellesley Hospital 2013

Newton Wellesley Hospital 2013 Newton Wellesley Hospital 20 Standard 4.6 Assessment and Evaluation of Treatment Planning Endometrial Cancer Each year a physician member of the cancer committee conducts a study to ensure that diagnostic

More information

Florida Cancer Data System STAT File Documentation Version 2019

Florida Cancer Data System STAT File Documentation Version 2019 Florida Cancer Data System STAT File Documentation Version 2019 Field Description NAACCR Item Recoded Patient ID Number 20 Addr at DX - State 80 X County at DX 90 Addr at DX Country 102 X Marital Status

More information

7/29/2014. Patterns of Care in Colon Cancer ( ) Literature. Background. Florida Cancer Data Compliance with NCCN Guidelines

7/29/2014. Patterns of Care in Colon Cancer ( ) Literature. Background. Florida Cancer Data Compliance with NCCN Guidelines Patterns of Care in Colon Cancer (21-212) Florida Cancer Data Compliance with FCDS Annual Meeting July 24-25, 214 Caribe Royale Resort Orlando, Florida Background O NCCN guidelines are referenced extensively

More information

NPCR s TNM Stage Calculator

NPCR s TNM Stage Calculator NPCR s TNM Stage Calculator A Tool for Central Registry Quality Control and Consolidation Assistance NAACCR Annual Meeting June 16, 2016 Jennifer Seiffert Northrop Grumman Under contract to NPCR Joseph

More information

General Information. Please silence cell phones. Locations Restrooms to the left of the ballroom, or to your right by the elevators

General Information. Please silence cell phones. Locations Restrooms to the left of the ballroom, or to your right by the elevators American American College College of of Surgeons 2013 Content 2014 Content cannot be be reproduced or or repurposed without written permission of of the the American College College of Surgeons. of Surgeons.

More information

ARDS. of the Commission on Cancer. Volume II: Registry Operations and Data Standards (ROADS) Revised 1/1/98

ARDS. of the Commission on Cancer. Volume II: Registry Operations and Data Standards (ROADS) Revised 1/1/98 STAND ANDARDS ARDS of the Commission on Cancer Volume II: Registry Operations and Data Standards (ROADS) Revised 1/1/98 1998 Commission on Cancer, American College of Surgeons Commission on Cancer 633

More information

Collecting Cancer Data: Prostate Q&A. Overview. NAACCR Webinar Series June 11, 2009

Collecting Cancer Data: Prostate Q&A. Overview. NAACCR Webinar Series June 11, 2009 Collecting Cancer Data: Prostate NAACCR 2008-2009 Webinar Series June 11, 2009 Q&A Please submit all questions concerning webinar content through the Q&A panel Overview 2008-2009 NAACCR Webinar Series

More information

1 : Patient Details. 2 : Medical Aid Details. 3 : Practitioner Detail (Practice) 4 : Patient History

1 : Patient Details. 2 : Medical Aid Details. 3 : Practitioner Detail (Practice) 4 : Patient History 1 : Patient Details Surname: Firstname: Initials: ID Number: First Diagnosed: Gender: Telephone: CellPhone: Dependant Code: Birth: Postal Address Fax: Email: 2 : Medical Aid Details Principal Member: Membership

More information

Interactive Discussion of Part I CS Coding Instructions: Working the Cases

Interactive Discussion of Part I CS Coding Instructions: Working the Cases Interactive Discussion of Part I CS Coding Instructions: Working the Cases April Fritz, RHIT, CTR Donna M. Gress, RHIT, CTR Jennifer Ruhl, RHIT, CCS, CTR This presentation was supported by the Cooperative

More information

Web Plus Instructions Radiation CCR

Web Plus Instructions Radiation CCR Web Plus Instructions Radiation CCR To begin entering Abstracts through Web Plus, you must first log into https://webplus.njscr.org/webplus/logonen.aspx with credentials that are provided to you once your

More information

Introduction & Descriptors

Introduction & Descriptors AJCC 8 th Edition Staging Introduction & Descriptors Donna M. Gress, RHIT, CTR Technical Editor, AJCC Cancer Staging Manual First Author, Chapter 1: Principles of Cancer Staging Validating science. Improving

More information

12/10/2012 IMPROVING DATA QUALITY FCDS DATA QUALITY PROGRAM AUDITS, EDITS AND DATA QUALITY REPORTS. Continuing Education Hours. Presentation Outline

12/10/2012 IMPROVING DATA QUALITY FCDS DATA QUALITY PROGRAM AUDITS, EDITS AND DATA QUALITY REPORTS. Continuing Education Hours. Presentation Outline IMPROVING DATA QUALITY FCDS DATA QUALITY PROGRAM AUDITS, EDITS AND DATA QUALITY REPORTS FCDS Webcast Series Steven Peace, BS, CTR December 13, 2012 2 Continuing Education Hours NCRA CEU # 2012-065 Date(s)

More information

12/10/2012. Continuing Education Hours IMPROVING DATA QUALITY FCDS DATA QUALITY PROGRAM AUDITS, EDITS AND DATA QUALITY REPORTS

12/10/2012. Continuing Education Hours IMPROVING DATA QUALITY FCDS DATA QUALITY PROGRAM AUDITS, EDITS AND DATA QUALITY REPORTS 2 IMPROVING DATA QUALITY FCDS DATA QUALITY PROGRAM AUDITS, EDITS AND DATA QUALITY REPORTS NCRA CEU # 2012-065 Continuing Education Hours Date(s) Event 7/26/2012-7/27/2012 2012-155 8/16/2012 Spons or FCDS

More information

Explaining Blanks and X, Ambiguous Terminology and Support for AJCC Staging

Explaining Blanks and X, Ambiguous Terminology and Support for AJCC Staging Explaining Blanks and X, Ambiguous Terminology and Support for AJCC Staging Donna M. Gress, RHIT, CTR Validating science. Improving patient care. This presentation was supported by the Cooperative Agreement

More information

Explaining Blanks and X, Ambiguous Terminology and Support for AJCC Staging

Explaining Blanks and X, Ambiguous Terminology and Support for AJCC Staging Explaining Blanks and X, Ambiguous Terminology and Support for AJCC Staging Donna M. Gress, RHIT, CTR Validating science. Improving patient care. This presentation was supported by the Cooperative Agreement

More information

Q&A. Fabulous Prizes. Collecting Cancer Data: Breast 4/4/13. NAACCR Webinar Series Collecting Cancer Data Breast

Q&A. Fabulous Prizes. Collecting Cancer Data: Breast 4/4/13. NAACCR Webinar Series Collecting Cancer Data Breast Collecting Cancer Data Breast NAACCR 2012 2013 Webinar Series Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching this webinar

More information

A CENTRAL REGISTRY RELIABILITY STUDY

A CENTRAL REGISTRY RELIABILITY STUDY A CENTRAL REGISTRY RELIABILITY STUDY Visual Editor TNM & Summary Stage Staging Skill Assessment Donna M. Hansen, CTR Auditor & Education Training Coordinator California Cancer Registry NAACCR June 16,

More information

Prostate Case Scenario 1

Prostate Case Scenario 1 Prostate Case Scenario 1 H&P 5/12/16: A 57-year-old Hispanic male presents with frequency of micturition, urinary urgency, and hesitancy associated with a weak stream. Over the past several weeks, he has

More information

The Quality of Cancer Registry Data: Preliminary Results from CDC-NPCR s Patterns of Care Study

The Quality of Cancer Registry Data: Preliminary Results from CDC-NPCR s Patterns of Care Study The Quality of Cancer Registry Data: Preliminary Results from CDC-NPCR s Patterns of Care Study Robert R. German, DrPH, MPH; Tim Byers, MD, MPH; Holly Wolf, PhD, MSPH; Jen Wike, MBA, MPH; Linda Alley,

More information

NAACCR 2018 IMPLEMENTATION WEBINAR

NAACCR 2018 IMPLEMENTATION WEBINAR If you experience technical difficulties, Please call us at 217 698 0800 x 111 NAACCR 2018 IMPLEMENTATION WEBINAR NAACCR 2018 IMPLEMENTATION WG DECEMBER 18, 2017 HOUSEKEEPING We will address all questions

More information

NPCR CLINICAL EDIT CHECKS

NPCR CLINICAL EDIT CHECKS NPCR CLINICAL EDIT CHECKS FCDS Annual Meeting July 26, 2013 Sunrise, Flrida Steven Peace, CTR FCDS Data Quality Staff PURPOSE OF CLINICAL EDIT CHECKS The primary purpse f the Clinical Check edits is t

More information

5/8/2014. AJCC Stage Introduction and General Rules. Acknowledgements* Introduction. Melissa Pearson, CTR North Carolina Central Cancer Registry

5/8/2014. AJCC Stage Introduction and General Rules. Acknowledgements* Introduction. Melissa Pearson, CTR North Carolina Central Cancer Registry AJCC Stage Introduction and General Rules Linda Mulvihill Public Health Advisor NCRA Annual Meeting May 2014 National Center for Chronic Disease Prevention and Health Promotion Division of Cancer Prevention

More information

Case Scenario 1. The patient has now completed his neoadjuvant chemoradiation and has been cleared for surgery.

Case Scenario 1. The patient has now completed his neoadjuvant chemoradiation and has been cleared for surgery. Case Scenario 1 July 10, 2010 A 67-year-old male with squamous cell carcinoma of the mid thoracic esophagus presents for surgical resection. The patient has completed preoperative chemoradiation. This

More information

Collecting Cancer Data: Pancreas

Collecting Cancer Data: Pancreas Collecting Cancer Data: Pancreas NAACCR 2011 2012 Webinar Series 1/5/2012 Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching this

More information

The Commission on Cancer: Reengineering the National Cancer Data Base

The Commission on Cancer: Reengineering the National Cancer Data Base The Commission on Cancer: Reengineering the National Cancer Data Base Stephen B. Edge MD FACS Chair Commission on Cancer American College of Surgeons Alfiero Chair of Breast Oncology Professor of Surgery

More information

ACOS Inquiry and Response Selected Inquires CS Tumor Size/Extension Evaluation, CS Lymph Nodes Evaluation, CS Metastasis at Diagnosis Evaluation *

ACOS Inquiry and Response Selected Inquires CS Tumor Size/Extension Evaluation, CS Lymph Nodes Evaluation, CS Metastasis at Diagnosis Evaluation * ACOS Inquiry and Response Selected Inquires CS Tumor Size/Extension Evaluation, CS Lymph Nodes Evaluation, CS Metastasis at Diagnosis Evaluation * CS Tumor Size/Extension Evaluation 24842 12/11/2007: Q:

More information

The Death Clearance Process: What Do We Gain From Our Efforts?

The Death Clearance Process: What Do We Gain From Our Efforts? The Death Clearance Process: What Do We Gain From Our Efforts? Colleen G. Sherman Maria J. Schymura April A. Austin Baozhen Qiao NAACCR 2012 Objectives Demonstrate the variability of resolution from follow

More information

Utilization of OncoType DX Test for

Utilization of OncoType DX Test for Utilization of OncoType DX Test for Breast Cancer in the Community Setting XC Wu, XR Li, V Petkov, MC Hsieh, M Loch, PA Andrews, VW Chen 2016 NAACCR Annual Conference June 8, 2016 Background Chemotherapy

More information

What s New in 2012 FCDS Annual Meeting Review

What s New in 2012 FCDS Annual Meeting Review What s New in 2012 FCDS Annual Meeting Review FCDS Educational Webcast Series August 16, 2012 FCDS Staff Steven Peace, CTR 2012 FORDS Cancer Program Standards CSv02.04 1 What is Cancer / What is Reportable

More information

Case Scenario. 7/13/12 Anterior floor of mouth biopsy: Infiltrating squamous cell carcinoma, not completely excised.

Case Scenario. 7/13/12 Anterior floor of mouth biopsy: Infiltrating squamous cell carcinoma, not completely excised. Case Scenario 7/5/12 History A 51 year old white female presents with a sore area on the floor of her mouth. She claims the area has been sore for several months. She is a current smoker and user of alcohol.

More information

Case Scenario 1 Worksheet. Primary Site C44.4 Morphology 8743/3 Laterality 0 Stage/ Prognostic Factors

Case Scenario 1 Worksheet. Primary Site C44.4 Morphology 8743/3 Laterality 0 Stage/ Prognostic Factors CASE SCENARIO 1 9/10/13 HISTORY: Patient is a 67-year-old white male and presents with lesion located 4-5cm above his right ear. The lesion has been present for years. No lymphadenopathy. 9/10/13 anterior

More information

Lesson 8 Classifications

Lesson 8 Classifications Lesson 8 Classifications Donna M. Gress, RHIT, CTR Validating science. Improving patient care. This presentation was supported by the Cooperative Agreement Number DP13-1310 from The Centers for Disease

More information

SAMPLE. Dental Claim Form. X Patient/Guardian Signature. X Subscriber Signature. X Signed (Treating Dentist) 54. NPI 55.

SAMPLE. Dental Claim Form. X Patient/Guardian Signature. X Subscriber Signature. X Signed (Treating Dentist) 54. NPI 55. HEADER INFORMATION 1. Type of Transaction (Mark all applicable boxes) Dental Claim Form fold fold Statement of Actual Services EPSDT / Title XIX 2. Predetermination/Preauthorization Number RECORD OF SERVICES

More information

Case Scenario 1. 7/13/12 Anterior floor of mouth biopsy: Infiltrating squamous cell carcinoma, not completely excised.

Case Scenario 1. 7/13/12 Anterior floor of mouth biopsy: Infiltrating squamous cell carcinoma, not completely excised. Case Scenario 1 7/5/12 History A 51 year old white female presents with a sore area on the floor of her mouth. She claims the area has been sore for several months. She is a current smoker and user of

More information

10. HPV-Mediated (p16+) Oropharyngeal Cancer

10. HPV-Mediated (p16+) Oropharyngeal Cancer 1 Terms of Use The cancer staging form is a specific document in the patient record; it is not a substitute for documentation of history, physical examination, and staging evaluation, or for documenting

More information

AJCC 8 th Edition Staging. Introduction & Descriptors. Learning Objectives. This webinar is sponsored by

AJCC 8 th Edition Staging. Introduction & Descriptors. Learning Objectives. This webinar is sponsored by AJCC 8 th Edition Staging Introduction & Descriptors Donna M. Gress, RHIT, CTR Technical Editor, AJCC Cancer Staging Manual First Author, Chapter 1: Principles of Cancer Staging Validating science. Improving

More information

The Impact of E-Path Technology on the Ontario Cancer Registry. Operations

The Impact of E-Path Technology on the Ontario Cancer Registry. Operations The Impact of E-Path Technology on the Ontario Cancer Registry Pathology LIS Operations Presented at the NAACCR 2002 Cancer Informatics Workshop Toronto, Ontario June 2002 EDI Darlene Dale Manager, Ontario

More information

Pancreas Case Scenario #1

Pancreas Case Scenario #1 Pancreas Case Scenario #1 An 85 year old white female presented to her primary care physician with increasing abdominal pain. On 8/19 she had a CT scan of the abdomen and pelvis. This showed a 4.6 cm mass

More information

Boot Camp /5/15

Boot Camp /5/15 Abstracting & Coding Boot Camp: Cancer Case Scenarios 2014-2015 NAACCR Webinar Series March 5, 2015 Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have

More information

2018 Updates to National Standards

2018 Updates to National Standards 2018 Updates to National Standards 1 F C D S A N N U A L C O N F E R E N C E O R L A N D O, F L O R I D A 7 / 2 6 / 2 0 1 7 S T E V E N P E A C E, C T R ICD-O-3 New Histology Codes ICD-O-3 Behavior Changes

More information